COVID-19 Antibody Therapy

COVID-19 Antibody Therapy was approved by the United States Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) declaration for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients who qualify for treatment.  This therapy has been proven to keep patients from worsening to the point of requiring hospitalization due to COVID-19 by 87%.

This therapy is not a substitute for a COVID-19 vaccine.

COVID-19 Antibody Therapy was approved by the United States Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) declaration for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients who qualify for treatment. This therapy has been proven to keep patients from worsening to the point of requiring hospitalization due to COVID-19 by 87%.

COVID-19 Antibody Therapy

What you should know.

How COVID-19 Antibody Therapy Works:

Who can receive this therapy?

How long does it take to receive this therapy?

How effective is it?

Are there any side effects or contraindications?

Can this be used instead of vaccine?

What are the costs?

Anything else I should know?

Do you believe you're a candidate and would like to receive this therapy? Click the button below:

COVID-19 Employer Testing Information